TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive NCI plans 11-16 percent budget cuts in new grants to maintain R01 payline at 20th percentile. November 28, 2003
TCL Archive Army Accepting Letters of Intent For Research in Breast Cancer; Plans Announcement In Sept. July 16, 1993
TCL Archive In Brief: House Passes Bill Extending Saccharin Status To 1981; Execs No Enthusiastic Over New SES August 3, 1979
TCL Archive NSABP Agrees To Three-Month Search for Chairman Candidates, Review Of Plans June 10, 1994
